Product logins

Find logins to all Clarivate products below.


Aesthetic Injectables | Market Insights | Asia Pacific (Supplemental) | 2025

The Asia Pacific aesthetic injectable market will experience rapid growth through 2033 driven by innovations and unique product offerings from key market leaders. Players in this market will help to support growth through new and differentiated products; the emergence of domestic players with low-cost offerings will also expand the availability of aesthetic injectables and make them more affordable for patients. Increasing acceptance and awareness of aesthetic procedures, along with a diversifying patient demographic, and growing patient pool including nontraditional patient groups such as men and younger individuals are anticipated to further fuel the demand for these treatments.

Related Medtech Insights Reports

Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
Aortic Repair Devices – Market Insights – Asia Pacific
The Asia Pacific aortic repair device market is projected to experience robust growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent…
Report
Aesthetic Injectables – Market Insights – Middle East
The Middle Eastern aesthetic injectable market will see strong growth, driven by the rising awareness and acceptability of these procedures due to the growing influence of social media, as well as…
Report
Aesthetic Injectables – Market Insights – Latin America
The Latin American aesthetic injectables market will expand through 2035, driven by ongoing product innovation and differentiation strategies among key competitors, as well as the increasing…
Report
Cardiac Rhythm Management Devices | Market Insights | Asia Pacific (Supplemental) | 2025
The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…